Equity Components [Axis] Common Stock [Member] Additional Paid-in Capital [Member] Retained Earnings [Member] AOCI Attributable to Parent [Member] Concentration Risk Benchmark [Axis] Accounts Receivable [Member] Concentration Risk Type [Axis] Customer Concentration Risk [Member] Customer [Axis] Customer 1 [Member] Customer 2 [Member] Customer 3 [Member] Antidilutive Securities [Axis] Share-Based Payment Arrangement, Option [Member] Restricted Stock [Member] Loan Agreement [Member] Warrant [Member] Product and Service [Axis] Product [Member] License [Member] Revenue Benchmark [Member] Rebates [Member] Prompt Pay [Member] Co-payment Assistance [Member] Financial Instrument [Axis] US Treasury Securities [Member] US Government Corporations and Agencies Securities [Member] Certificates of Deposit [Member] Long-Lived Asset, Class [Axis] Laboratory Equipment [Member] Furniture, Software and Office Equipment [Member] Leasehold Improvements [Member] Construction in Progress [Member] Equipment [Member] Measurement Frequency [Axis] Fair Value, Recurring [Member] Asset Class [Axis] Money Market Funds [Member] Fair Value Hierarchy and NAV [Axis] Fair Value, Inputs, Level 1 [Member] Fair Value, Inputs, Level 2 [Member] Fair Value, Inputs, Level 3 [Member] Money Market Deposit Account [Member] Warrant Liabilities [Member] Class of Warrant or Right [Axis] 2021 Public Offering Warrants [Member] 2022 Private Placement Offering [Member] 2024 Loan Agreement [Member] 2024 Loan Agreement One [Member] Measurement Input Type [Axis] Measurement Input, Share Price [Member] Measurement Input, Expected Term [Member] Statistical Measurement [Axis] Minimum [Member] Maximum [Member] Measurement Input, Risk Free Interest Rate [Member] Measurement Input, Price Volatility [Member] Measurement Input, Expected Dividend Rate [Member] Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Loan and Security Agreement [Member] Vesting [Axis] Tranche 1 [Member] Tranche 2 [Member] Discretionary Tranche [Member] Legal Entity [Axis] Avenue [Member] Avenue 2 [Member] 2024 Pre-Funded Warrants [Member] Open Market Sale Agreements [Member] Jefferies LLC [Member] Sale of Stock [Axis] Private Placement Offerings [Member] Pre Funded Warrant [Member] Common Stock and Accompanying Warrant [Member] Pre-Funded Warrant and Accompanying Warrant [Member] 2023 Pre-Funded Warrants [Member] Award Type [Axis] July 2025 Avenue Warrants [Member] Plan Name [Axis] 2023 Equity Incentive Plan [Member] Inducement Plan [Member] SIR-T Technology for PSMA-Positive Prostate Cancer [Member] Event Based Milestone Payments [Member] License Agreement Relating to AAV Capsids [Member] Sales Based Milestone Payments [Member] Sublicense And Inventory Purchase Agreements [Member] Sublicense Agreement Relating to Rett Syndrome [Member] Research and Development Arrangement, Contract to Perform for Others, Type [Axis] License Agreement Terms [Member] Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] Statement of Financial Position [Abstract] ASSETS Current assets: Cash and cash equivalents Short-term investments Accounts receivable, net Inventory Other receivables Prepaid expenses and other current assets Total current assets Property and equipment, net Operating lease right-of-use assets Other assets Total assets LIABILITIES AND STOCKHOLDERS’ EQUITY Current liabilities: Accounts payable Accrued expenses Current portion of long-term debt Current portion of operating lease liability Payable to licensor Accrued taxes and other current liabilities Total current liabilities Long-term operating lease liabilities Long-term debt Deferred revenue Warrant liabilities Total liabilities Commitments and contingencies Preferred stock - $0.01 par value; authorized 2,000,000 shares; No shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively Common stock - $0.01 par value; authorized 200,000,000 shares; 56,866,381 and 55,043,413 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively Additional paid-in capital Accumulated deficit Accumulated other comprehensive (loss) income Total stockholders’ equity Total liabilities and stockholders’ equity Preferred stock, par value Preferred stock, shares authorized Preferred stock, shares issued Preferred stock, shares outstanding Common stock, par value Common stock, shares authorized Common stock, shares issued Common stock, shares outstanding Income Statement [Abstract] Revenues: Product revenue, net Costs and expenses: Cost of sales Research and development Selling, general and administrative Total costs and expenses Loss from operations Interest income Interest expense Change in fair value of warrant liabilities Other income, net Loss before income taxes Income tax expense Net loss Basic loss per common share Diluted loss per common share Weighted average number of common shares outstanding - basic Weighted average number of common shares outstanding - diluted Other comprehensive loss: Change in unrealized losses related to available-for-sale debt securities Comprehensive loss Statement [Table] Statement [Line Items] Balance Balance, shares Stock-based compensation expense Issuance of common stock in connection with restricted share awards Issuance of common stock in connection with restricted share awards, shares Net loss Other comprehensive loss Issuance of common stock in connection with restricted share awards, net of cancellations and shares settled for tax withholding settlement Issuance of common stock in connection with restricted share awards, net of cancellations and shares settled for tax withholding settlement, shares Issuance of common stock, net of offering costs under open market sale agreement (ATM) Issuance of common stock, net of offering costs under open market sale agreement (ATM), shares Balance Balance, shares Statement of Cash Flows [Abstract] Cash flows from operating activities: Adjustments to reconcile net loss to cash used in operating activities: Depreciation and amortization Stock-based compensation expense Change in fair value of warrant liabilities Accretion and interest on short-term investments Amortization of right-of-use lease assets Non-cash interest Change in operating assets and liabilities: Accounts receivable Inventory Other receivables Prepaid expenses and other current assets Other assets Accounts payable and accrued expenses Lease liabilities Change in payable to licensor Deferred revenue Accrued taxes and other current liabilities Net cash used in operating activities Cash flows from investing activities: Capital expenditures Purchases of short-term investments Proceeds from maturities of short-term investments Net cash provided by investing activities Cash flows from financing activities: Proceeds from ATM sales of common stock, net of issuance costs Payments related to net settlement of restricted share awards Payments of long-term debt Net cash (used in) provided by financing activities Net decrease in cash, cash equivalents and restricted cash Cash, cash equivalents and restricted cash at beginning of period Cash, cash equivalents and restricted cash at end of period Supplemental cash flow information: Cash and cash equivalents Restricted cash Total cash, cash equivalents and restricted cash Supplemental non-cash flow information: Right-of-use asset obtained in exchange for new operating lease liabilities Changes in accrued property and equipment Cash paid for interest Pay vs Performance Disclosure [Table] Executive Category [Axis] Individual [Axis] Adjustment to Compensation [Axis] Measure [Axis] Pay vs Performance Disclosure, Table Company Selected Measure Name Named Executive Officers, Footnote Peer Group Issuers, Footnote Changed Peer Group, Footnote PEO Total Compensation Amount PEO Actually Paid Compensation Amount Adjustment To PEO Compensation, Footnote Non-PEO NEO Average Total Compensation Amount Non-PEO NEO Average Compensation Actually Paid Amount Adjustment to Non-PEO NEO Compensation Footnote Equity Valuation Assumption Difference, Footnote Compensation Actually Paid vs. Total Shareholder Return Compensation Actually Paid vs. Net Income Compensation Actually Paid vs. Company Selected Measure Total Shareholder Return Vs Peer Group Compensation Actually Paid vs. Other Measure Tabular List, Table Total Shareholder Return Amount Peer Group Total Shareholder Return Amount Net Income (Loss) Company Selected Measure Amount Other Performance Measure, Amount Adjustment to Compensation, Amount PEO Name Name Non-GAAP Measure Description Additional 402(v) Disclosure Pension Benefits Adjustments, Footnote Equity Awards Adjustments, Footnote Erroneously Awarded Compensation Recovery [Table] Restatement Determination Date [Axis] Restatement Determination Date Aggregate Erroneous Compensation Amount Erroneous Compensation Analysis Stock Price or TSR Estimation Method Outstanding Aggregate Erroneous Compensation Amount Aggregate Erroneous Compensation Not Yet Determined Name Forgone Recovery due to Expense of Enforcement, Amount Forgone Recovery due to Violation of Home Country Law, Amount Forgone Recovery due to Disqualification of Tax Benefits, Amount Forgone Recovery, Explanation of Impracticability Name Compensation Amount Restatement does not require Recovery Awards Close in Time to MNPI Disclosures [Table] Award Timing MNPI Disclosure Award Timing Method Award Timing Predetermined Award Timing MNPI Considered Award Timing, How MNPI Considered MNPI Disclosure Timed for Compensation Value Awards Close in Time to MNPI Disclosures, Table Name Underlying Securities Exercise Price Fair Value as of Grant Date Underlying Security Market Price Change Insider Trading Arrangements [Line Items] Material Terms of Trading Arrangement Name Title Rule 10b5-1 Arrangement Adopted Non-Rule 10b5-1 Arrangement Adopted Adoption Date Rule 10b5-1 Arrangement Terminated Non-Rule 10b5-1 Arrangement Terminated Termination Date Expiration Date Arrangement Duration Aggregate Available Rule 10b5-1 Arrangement Modified Non-Rule 10b5-1 Arrangement Modified Insider Trading Policies and Procedures [Line Items] Insider Trading Policies and Procedures Adopted Insider Trading Policies and Procedures Not Adopted Organization, Consolidation and Presentation of Financial Statements [Abstract] NATURE OF OPERATIONS Accounting Policies [Abstract] SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Revenue from Contract with Customer [Abstract] REVENUE Investments, Debt and Equity Securities [Abstract] SHORT-TERM INVESTMENTS Inventory Disclosure [Abstract] INVENTORY Property, Plant, and Equipment [Abstract] PROPERTY AND EQUIPMENT, NET Fair Value Disclosures [Abstract] FAIR VALUE MEASUREMENTS Payables and Accruals [Abstract] ACCRUED EXPENSES Leases LEASES Debt Disclosure [Abstract] DEBT Equity [Abstract] EQUITY Share-Based Payment Arrangement [Abstract] STOCK-BASED COMPENSATION LICENSE/SUPPLIER AGREEMENTS Segment Reporting [Abstract] SEGMENT INFORMATION Basis of Presentation Use of Estimates Accounts Receivable Other receivables Concentration of Credit Risk and Off-Balance Sheet Risk Inventory and Costs of Sales Credit Losses Segments Revenue Recognition Royalties Net Loss Per Share Recently Issued Accounting Pronouncements SCHEDULE OF ACCOUNTS RECEIVABLE SCHEDULE OF ACCOUNTS RECEIVABLE, NET FROM CUSTOMERS SCHEDULE OF ANTI-DILUTIVE SECURITIES EXCLUDED FROM COMPUTATION OF EARNINGS PER SHARE SCHEDULE OF REVENUE SCHEDULE OF CONCENTRATION OF CREDIT RISK SCHEDULE OF CHANGES IN ALLOWANCES AND DISCOUNTS TABLE TEXT BLOCK SCHEDULE OF ACTIVITY ON DEFERRED REVENUE SCHEDULE OF AVAILABLE FOR SALE SHORT-TERM INVESTMENTS SCHEDULE OF INVENTORY SCHEDULE OF PROPERTY AND EQUIPMENT SCHEDULE OF FAIR VALUE, ASSETS AND LIABILITIES MEASURED ON RECURRING AND NON-RECURRING BASIS SCHEDULE OF OUTSTANDING WARRANT LIABILITIES SCHEDULE OF ACTIVITY OF WARRANT LIABILITIES SCHEDULE OF ESTIMATE FAIR VALUE OF WARRANTS SCHEDULE OF ACCRUED EXPENSES SUMMARY OF OPERATING LEASE LIABILITIES SCHEDULE OF COMPONENTS OF LEASE COST SCHEDULE OF MATURITIES OF OPERATING LEASE LIABILITIES SCHEDULE OF DEBT AND NET OF DEBT ISSUANCE COSTS SCHEDULE OF FUTURE PAYMENT OBLIGATIONS SCHEDULE OF STOCK BASED COMPENSATION SCHEDULE OF STOCK OPTION ACTIVITY SCHEDULE OF RESTRICTED STOCK AWARD ACTIVITY SCHEDULE OF SIGNIFICANT EXPENSE CATEGORIES Product sales License revenues Total accounts receivable, net Nature of Operation, Product Information, Concentration of Risk [Table] Product Information [Line Items] Concentration risk, percentage Antidilutive Security, Excluded EPS Calculation [Table] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Total Employee retention credits receivables Unfounded exercise price per share Disaggregation of Revenue [Table] Disaggregation of Revenue [Line Items] Total revenues Balance at December 31, 2025: Provision Payments/Credits Balance at March 31, 2026 Deferred revenue balance as of December 31, 2025 Additions to deferred revenue during the period Revenue recognized during the period Deferred revenue balance as of March 31, 2026 Marketable Securities [Table] Marketable Securities [Line Items] Amortized cost Gross Unrealized Gain Gross Unrealized Loss Fair Value Available-for-sale securities realized gain loss Raw materials Work-in-progress Finished goods Total inventory Inventory write-down Property, Plant, and Equipment [Table] Property, Plant, and Equipment [Line Items] Total property and equipment, cost Less: accumulated depreciation Total property and equipment, net Depreciation expense Fair Value, Recurring and Nonrecurring [Table] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Cash equivalents fair value Short-term investments fair value Total assets measured at fair value Fair value, liabilities Total liabilities measured at fair value Class of Warrant or Right [Table] Class of Warrant or Right [Line Items] Outstanding warrants liabilities Warrants, exercise price Warrant liabilities as of December 31, 2025 Issuance of warrants Gain recognized in earnings from change in fair value Warrant liabilities as of March 31, 2026 Fair Value Measurement Inputs and Valuation Techniques [Table] Fair Value Measurement Inputs and Valuation Techniques [Line Items] Warrants measurement input Warrants measurement input Estimated fair value of loan agreement Accrued employee compensation Accrued contracted services and other Accrued rebates Total accrued expenses Summary Of Operating Lease Liabilities Current operating lease liability Non-current operating lease liability Total operating lease liability Schedule Of Components Of Lease Cost Operating lease cost Variable lease cost Short-term lease cost Total operating lease costs 2026, remainder 2027 2028 2029 2030 Total undiscounted operating lease payments Less: imputed interest Present value of operating lease liabilities Operating lease expense Weighted average remaining term Weighted average discount rate Loan Agreement Principal Accreted final payment fee Unamortized debt issuance costs and discounts Total long-term debt Less: current maturities Long-term debt, net of current maturities 2026, remainder 2027 Total principal Schedule of Long-Term Debt Instruments [Table] Debt Instrument [Line Items] Aggregate principal amount Aggregate principal amount Effective interest rate Stated interest rate Percentage fee, description Unrestricted cash Outstanding principal amount of loan Exercise price of warrants percent Conversion Price Aggregate transaction amount Participation right description Warrants purchase amount Preferred stock shares authorized Preferred stock par value Preferred stock shares outstanding Shares issued Exercise price Warrants purchase, shares Warrants exercise price Proceeds from public offering Stock issuance costs Additional paid-in capital Warrant liabilities Shares of common stock issuable upon exercise of warrants Warrants maturity date Warrants exercised Purchase price of common stock Shares issuance costs Offering price Aggregate sale price Purchase of warrants Exercise price Additional paid in capital stock reduction Proceeds from warrant liability Fair value of warrants Warrant outstanding Exercise price per share Research and development Selling, general and administrative Total stock-based compensation expense Number of options, outstanding balance Weighted average exercise price, outstanding balance Weighted average remaining contractual term (years), outstanding Aggregate intrinsic value, outstanding balance Number of options, granted Weighted average exercise price, granted Number of options, cancelled/forfeited Weighted average exercise price, cancelled/forfeited Number of options, exercised Weighted average exercise price, exercised Number of options, outstanding balance Weighted average exercise price, outstanding balance Aggregate intrinsic value, outstanding balance Number of options, exercisable Weighted average exercise price, exercisable Weighted average remaining contractual term (years), exercisable Aggregate intrinsic value, exercisable Number of options, unvested Weighted average exercise price, unvested Weighted average remaining contractual term (years), unvested Aggregate intrinsic value, unvested Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Restricted common stock awards, balance Weighted-average grant date fair value, balance Restricted common stock awards, granted Weighted-average grant date fair value, granted Restricted common stock awards, cancelled/forfeited Weighted-average grant date fair value, cancelled/forfeited Restricted common stock awards, vested Weighted-average grant date fair value, vested Restricted common stock awards, balance Weighted-average grant date fair value, balance Increase in shares authorized Shares available for grant Granted Compensation cost related to non-vested options not recognized Weighted average period total compensation costs related to non-vested options Compensation cost related to restricted common stock not recognized Weighted average compensation costs related to restricted common stock Fair value of restricted stock awards that vested Collaborative Arrangement and Arrangement Other than Collaborative [Table] Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] Upfront payment of contract execution Future event-based milestone payments Fixed consideration Variable consideration Accounts Receivable, after Allowance for Credit Loss Long-Term Purchase Commitment, Amount Segment Reporting [Table] Segment Reporting [Line Items] Research and development costs Salaries & related costs Non-cash stock-based compensation Other research and development costs Total research and development costs General and administrative costs Salaries & related costs Non-cash stock-based compensation Commercial costs Other general and administrative costs Total general and administrative costs Other segment items Non-Rule 10b5-1 Arrangement Modified. Rule 10b51 Arr Modified Flag. Changes in accrued property and equipment. Payments related to net settlement of restricted share awards Current portion payable to licensor Product sales. License revenues. Laboratory Equipment [Member] Furniture, Software and Office Equipment [Member] Customer 1 [Member] Customer 2 [Member] Customer 3 [Member] Royalty Policy [Text Block] Money Market Deposit Account [Member] Warrant Liabilities [Member] Schedule Of Outstanding Warrant Liabilities [Table Text Block] 2021 Public Offering Warrants [Member] 2022 Private Placement Offering [Member] 2024 Loan Agreement [Member] 2024 Loan Agreement One [Member] Schedule Of Activity Warranty Liability [Table Text Block] Warrant liabilities. Gain recognized in earnings from change in fair value. Schedule of Operating Lease Liabilities [Table Text Block] Accreted final payment fee. Loan and Security Agreement [Member] Tranche 1 [Member] Tranche 2 [Member] Discretionary Tranche [Member] Exercise price of warrants percent. Participation right description. Avenue [Member] Avenue 2 [Member] Loan Agreement [Member] Recently Adopted Accounting Pronouncements [Policy Text Block] Schedule Of Revenue [Table Text Block]  Schedule Of Accounts Receivable, Net From Customers Table Text Block  Schedule Of Revenue From Product Sales Table Text Block.  Schedule Of Changes In Allowances And Discounts Table Text Block. Allowances and discounts. Provision for allowances and discounts. Payments credits for allowances and discounts. Rebates [Member] Prompt Pay [Member] Co-payment Assistance [Member] Fair value warrant liabilities. 2024 Pre-Funded Warrants [Member] Gross proceeds from issuance of common stock. Open Market Sale Agreements [Member] Jefferies LLC [Member] Private Placement Offerings [Member] Pre Funded Warrant [Member] Common Stock And Accompanying Warrant [Member] Pre Funded Warrant And Accompanying Warrant [Member] 2023 Pre-Funded Warrants [Member] July 2025 Avenue Warrants [Member] 2023 Equity Incentive Plan [Member] Inducement Plan [Member] Share based compensation arrangement by share based payment award options unvested weighted average remaining contractual term1. Sharebased compensation arrangement by sharebased payment award options unvested intrinsic value1 . Sharebased compensation arrangement by sharebased payment award other than options vested in period fair value. Sublicense And Inventory Purchase Agreements [Member] Event-Based Milestone Payments [Member] License Agreement [Member] License Agreement Relating to AAV Capsids [Member] Sales-Based Milestone Payments [Member] Sublicense Agreement Relating to Rett Syndrome [Member] Precommercial preparation costs. Other segments. Allocated share based compensation expense research and development. Allocated share based compensation expense general and administrative. Salaries and related costs research and development costs. Non cash stock based compensation research and development costs. Other research and development expenses. Salaries and related costs general and administrative costs. Non cash stock based compensation general and administrative costs. Commercial costs general and administrative costs. Other general and administrative expenses. Upfront payment of contract execution. Future event-based milestone payments. SIR-T Technology for PSMA-Positive Prostate Cancer [Member] Assets, Current Assets Liabilities, Current Liabilities Equity, Attributable to Parent Liabilities and Equity Costs and Expenses Operating Income (Loss) Interest Expense, Operating and Nonoperating Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Comprehensive Income (Loss), Net of Tax, Attributable to Parent Shares, Outstanding Share-Based Payment Arrangement, Noncash Expense Accretion (Amortization) of Discounts and Premiums, Investments Increase (Decrease) in Accounts Receivable Increase (Decrease) in Inventories Increase (Decrease) in Other Receivables Increase (Decrease) in Prepaid Expense and Other Assets Increase (Decrease) in Other Noncurrent Assets Increase (Decrease) in Deferred Revenue Increase (Decrease) in Accrued Taxes Payable Cash Provided by (Used in) Operating Activity, Including Discontinued Operation Payments to Acquire Property, Plant, and Equipment Payments to Acquire Short-Term Investments Cash Provided by (Used in) Investing Activity, Including Discontinued Operation PaymentsRelatedToNetSettlementOfRestrictedShareAwards Repayments of Long-Term Debt Cash Provided by (Used in) Financing Activity, Including Discontinued Operation Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Including Discontinued Operation Restricted Cash and Cash Equivalent Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation Forgone Recovery, Individual Name Outstanding Recovery, Individual Name Awards Close in Time to MNPI Disclosures, Individual Name Trading Arrangement, Individual Name Receivable [Policy Text Block] AllowancesAndDiscounts Debt Securities, Available-for-Sale, Unrealized Loss Property, Plant, and Equipment, Accumulated Depreciation, Depletion, and Amortization WarrantLiabilities GainRecognizedInEarningsFromChangeInFairValue Warrants and Rights Outstanding, Term Lease, Cost Lessee, Operating Lease, Liability, to be Paid Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net Long-Term Debt Long-Term Debt, Maturity, Remainder of Fiscal Year Long-Term Debt, Maturity, Year One Debt Instrument, Periodic Payment, Principal Additional Paid in Capital, Common Stock FairValueWarrantLiabilities AllocatedShareBasedCompensationExpenseResearchAndDevelopment AllocatedShareBasedCompensationExpenseSellingGeneralAndAdministrative Share-Based Payment Arrangement, Expense Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period SalariesAndRelatedCostsGeneralAndAdministrativeCosts NonCashStockBasedCompensationGeneralAndAdministrativeCosts